痴呆症护理研究和心理社会因素
Gabriela Bezerra Sorato1, Jessica Vargas Lopes1, Ana Carolina Gomes Petry1
1Fundação Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
新的单克隆抗体 (mAbs) 在减少粉样质斑块和减缓早期阿尔茨海默病 (AD) 的认知衰退方面表现有前途. 然而,潜在的风险和高成本需要进一步研究临床适用性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,目前的治疗主要是治疗症状.
- 新型抗粉样蛋白单克隆抗体 (mAbs) 提供了一种针对β-粉样蛋白斑块的新疗法.
- 这些新兴AD疗法的疗效和安全性正在进行调查.
研究的目的:
- 审查关于在阿尔茨海默病 (AD) 中使用单克隆抗体 (mAbs) 的当前文献.
- 评估新型mAb疗法对AD的疗效和安全性.
- 确定基于mAb的AD治疗的挑战和未来研究方向.
主要方法:
- 进行了叙事文学评论.
- 在PubMed/MEDLINE进行了自2019年以来发表的文章的搜索.
- 关键词包括"阿尔茨海默病"",治疗"",单克隆抗体"和"小说".
主要成果:
- 包括四项研究,重点关注阿杜卡努马布,莱卡尼马布和多纳尼马布.
- 这些mAbs在减少β-粉样蛋白斑块和减缓早期AD的认知衰退方面表现出有效性.
- 与粉样蛋白相关的成像异常等不良影响和高成本带来了重大挑战.
结论:
- 单克隆抗体代表了阿尔茨海默氏症治疗的重大进展,特别是在早期阶段.
- 需要进一步的强大研究来确认临床适用性,重点关注安全性,基础设施和成本效益.
- 解决这些挑战对于推进基于mAb的AD治疗方法至关重要.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K